Corcept director granted options on 12,500 shares

Corcept Therapeutics director Kimberly Park received a stock option grant for 12,500 shares of common stock.

Rhea-AI Filing Summary

Corcept Therapeutics director Kimberly Park received a stock option grant for 12,500 shares of common stock. The options were granted on May 21, 2026 with an exercise price of $59.69 per share and expire on May 21, 2036.

The award was reported as a grant or other acquisition and is held directly. Following this transaction, Park holds options covering 12,500 shares. According to the footnote, the options become exercisable in equal monthly installments over a one-year period starting on May 21, 2026, contingent on her continued service on each vesting date.

Insider Trade Summary

Grant/Award: 12,500 shares

Grant/Award 1 txn

Insider Park Kimberly

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	12,500	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 12,500 contracts (Direct)

Footnotes (1)

1. F1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

Key Figures

Option grant size: 12,500 shares Exercise price: $59.69 per share Expiration date: May 21, 2036 +2 more

5 metrics

Option grant size 12,500 shares Stock options granted May 21, 2026

Exercise price $59.69 per share Stock option strike price

Expiration date May 21, 2036 Option term end date

Underlying shares 12,500 shares Common stock underlying the options

Vesting schedule Monthly over one year From May 21, 2026, subject to continued service

Key Terms

Stock Option (right to buy), exercise price, Grant, award, or other acquisition, derivative securities, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

exercise price financial

"conversion_or_exercise_price: 59.6900"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

derivative securities financial

"transaction_type: derivative"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

exercisable ratably financial

"Exercisable ratably in equal installments on each monthly anniversary"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Corcept Therapeutics (CORT) report for Kimberly Park?

Corcept Therapeutics reported a grant of stock options to director Kimberly Park. She received options on 12,500 shares of common stock, awarded on May 21, 2026, as a compensation-related acquisition rather than an open-market stock purchase.

How many Corcept Therapeutics shares are covered by Kimberly Park’s new options?

The new stock option grant to Kimberly Park covers 12,500 shares of Corcept Therapeutics common stock. These options give her the right to buy that number of shares if she chooses to exercise them in the future, subject to vesting conditions.

What is the exercise price and expiration date of Kimberly Park’s Corcept options?

Kimberly Park’s stock options have an exercise price of $59.69 per share and an expiration date of May 21, 2036. She can choose to exercise vested portions any time before expiration, consistent with the award’s terms.

How do Kimberly Park’s Corcept stock options vest over time?

The options vest in equal monthly installments over one year starting May 21, 2026. Each monthly vesting date requires Kimberly Park’s continued service, meaning she must remain in her role for options to become exercisable gradually across that period.

Is Kimberly Park’s Corcept transaction a market purchase or a compensation grant?

The transaction is a compensation grant, not a market purchase. It is coded as a grant or award acquisition, with a transaction price of $0.00 and an exercise price of $59.69, reflecting options issued by the company rather than shares bought in the market.

What are Kimberly Park’s Corcept derivative holdings after this Form 4 transaction?

After the reported transaction, Kimberly Park holds stock options for 12,500 underlying shares of Corcept common stock. The filing shows these as directly owned derivative securities, representing her reported option position following the grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 05:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Park Kimberly

(Last) (First) (Middle)

C/O CORCEPT THERAPEUTICS INCORPORATED

101 REDWOOD SHORES PARKWAY

(Street)

REDWOOD CITY CALIFORNIA 94065

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC [ CORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$59.69	05/21/2026		A		12,500		(1)	05/21/2036	Common Stock	12,500	$0.00	12,500	D

Explanation of Responses:

1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.

	/s/ Joseph Douglas Lyon, as attorney-in-fact for Kimberly Park	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)